HA121-28 tablets

· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HA121-28 tablets, covering 2022-02-23 to 2022-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC) [Phase 2]